Case Pres PPT
-
Upload
peejay-padigdig-feliciano -
Category
Documents
-
view
224 -
download
0
Transcript of Case Pres PPT
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 1/56
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 2/56
Laboratory and
Diagnostic Procedures
Result Normal Values Interpretation
CBC
White Blood Cells(WBC)
Lymphocytes
Red Blood Cells
(RBC)
0.6
0.58
2.21
Adults: 5-10x109/L
Children: 6.2-
17.0x109/L
0.20-0.40
Male: 4.5-
6.0x109/L
Female: 4.0-
5.5x109/L
Lymphoblast’s quickly grows andreplace WBC in the bone marrow and
prevent from being made.
The bone marrow produces immaturecells that develop into leukemic white
blood cells called lymphoblasts. These
abnormal cells are unable to function
properly, and they can build up and
crowd out healthy cells.
Due to increased production of
Lymphocytes it results in decreased
production of RBC and resulting into
anemia which is one of the primary
symptoms of ALL.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 3/56
Laboratory and
Diagnostic Procedures
Result Normal Values Interpretation
Hemoglobin
Hematocrit
Segmenters
Monocytes
APC
Platelet count
61
0.19
0.25
0.07
28
Male: 120-170g/L
Female: 110-
150g/L
Male: 0.40-0.54
Female: 0.37-0.47
0.50-0.70
0-0.07
150-450x109/L
Changes in this level are due to changes
in the Red Blood Cell count and occur for
the same reason resulting to decrease
tissue perfusion and leading to pale skin.
Decreased in Hematocrit count is due to
decreased Red Blood Cell and resulting
into anemia.
Decreased in Segmenters is usually due
to decreased WBC count and occur for
the same reason.
Not remarkable
Because of decreased production of
Platelet, frequent bleeding results as
manifested by bruises.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 4/56
Laboratory and
Diagnostic Procedures
Result Normal Values Interpretation
ALT (SGPT)
AST (SGOT)
22.0
24.3
7 -56
5-40
There is no remarkable result in bothALT (SGPT) and AST (SGOT). Results
are both in normal range which
implies that there is no excessive
released in Aspartate
Aminotransferase (found in heart,
kidney, brain, muscle and liver) and
Alanine Aminotransferase (largely
found in liver). Liver detoxify
medicine normally (as the patient is in
still in chemotherapy).
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 5/56
Other Laboratory and Diagnostic
Procedures for ALL
Bone marrow test
• Doctors will classify blood cells in to thespecific types based on their size, shape and
other features• Look for certain changes in the cancer cells
and determine whether the leukemia cells
began from B lymphocytes or T lymphocytes.• This information helps the doctor develop a
treatment plan.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 6/56
X-rays
• Routine chest x-rays may be done if the doctor
suspects a lung infection. They may also bedone to look for enlarged lymph nodes in thechest.
Computed tomography (CT) scan• This test can help tell if any lymph nodes or
organs in your body are enlarged. It isn'tusually needed to diagnose ALL, but it may be
done if your doctor suspects leukemia cellsare growing in an organ, like your spleen.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 7/56
Magnetic resonance imaging (MRI) scan
• Like CT scans, MRI scans provide detailed images
of soft tissues in the body.• MRI scans are very helpful in looking at the brain
and spinal cord.
Ultrasound• Ultrasound uses sound waves and their echoes to
produce a picture of internal organs or masses.
•
Ultrasound can be used to look at lymph nodesnear the surface of the body or to look for
enlarged organs inside your abdomen such as the
kidneys, liver, and spleen.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 8/56
TREATMENT
In general, treatment for ALL falls into separate phases:
Induction therapy
•To kill most of the leukemia cells in the blood and bonemarrow.
Consolidation therapy
• Also called post-remission therapyDestroying the leukemia cells remaining in the brain orspinal cord.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 9/56
Maintenance therapy
• Prevents the leukemia cells from regrowing.
The treatments used in this stage are oftengiven at much lower doses.
Preventive treatment to the spinal cord
• Chemotherapy drugs are injected directly into
the fluid that covers the spinal cord.
• This kills cancer cells that can’t be reached by
chemotherapy drugs given by mouth or
through all intravenous line.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 10/56
Treatments may include:
Chemotherapy
• It uses drugs to kill cancer cells
• Typically used as an induction therapy for
children and adults with ALL.
• This can also be used in the consolidation and
maintenance therapy.
Targeted drug therapy
• Attack specific abnormalities present in the
cancer cells that may help them grow and
thrive.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 11/56
Radiation therapy
• Uses high-powered beams.
This is used if the cancer cells have spread to thecentral nervous system.
Stem cell transplant• Used as a consolidation therapy in people at high-
risk of relapse or for treating when it occurs.
•
This procedure allows someone with leukemia tore-establish healthy stem cells by replacing
leukemic bone marrow with leukemia-free flow.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 12/56
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 13/56
Generic
Name
Dosage/
frequency
and
Route of admin
Action Indicatio
n
Contra-
indicatio
n
Adverse
Reaction
Nursing
Management/Cons
ideration
CEFTAZIDI
ME
375 mg
every 8
hours
intraveno-usly
Slow IV
Third
generation
cephalospo
rin thatinhibits
cell-wall
synthesis,
promoting
osmoticinstability
usually
bactericidal
Serious
UTI and
lower
respiratory tract
infection
Patients
hypersen
sitive to
drug orother
cephalos
porin
Headache,
dizziness
,paresthesia
,seizures,phlebitis,
rashes,
urticaria
>before
administration, ask
patient if he is
allergic to penicillinor cephalloporins
>obtain specimen
for culture and
sensitivity tests
before giving firstdose
>therapy may
begin while
awaiting results
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 14/56
Generic
Name
Dosage/fre
quency and
Route of
admin
Action Indication Contra-
indication
Adverse
Reaction
Nursing
Management/C
onsideration
AMIKACIN
SULFATE
55mg every
8 hoursintravenous
ly(negative)
ANST
Inhibits
proteinsynthesis by
binding
directly to
the 3OS
ribosomal
subunit;bactericidal
erious
complicatedand recurrent
urinary tract
infections due
to these
organisms.
Contraindic
ated inpatientshyp
ersensitive
to drug or
other
aminoglyco
sides
Neuromusc
ularblockade
ototoxicity,a
zotemia,nep
hrotoxicity,i
ncrease in
urinaryexcretion of
casts
>obtain
specimen forculture and
sensitivity test
befoe giving first
dose,therapy
may begin
waiting results>evaluate
patients hearing
before and
dering therapy.if
he will bw
receiving drugfor longer than 2
weeks
>notify
prescriber if
patient has
tinnitus or
hearing loss
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 15/56
Generic
Name
Dosage/fr
equency
and
Route of
admin
Action Indication Contra-
indicatio
n
Adverse
Reaction
Nursing
Management/Cons
ideration
ACICLOVI
R
SODIUM
400mg/5
ml/5ml
every 6
hours per
orem
Interfere
s with
DNA
synthesis
and
inhibitsviral
multiplic
ation
First and
recurrent
episodes of
mucotaneous
herpes simplex
virus(HSV-1and HSV-2)
infections in
immmunocom
promized
patients
.severe firstepisode of
genitals herpes
in patients
who went
immunocompr
omized
Contrain
dicated
in
patients
hyperse
nsitivityto drug
Malaise,head
eche,enceph
alophatic
changes,naus
ea,vomiting,
diarrhea,hematuria,acut
e renal
failure,rash,it
ching.urticari
a,inflamation
or phlebitiisto injection
site
>dont give IM or
subcutaneously
>in patiennts with
renal disease on
dehydration and in
those taking othernephrotoxic
drug,monitor rena
function
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 16/56
Generic Name Dosage/
frequen
cy and
Route of
admin
Action Indicati
on
Contra-
indication
Adverse
Reaction
Nursing
Management/Consi
deration
RANITIDINE
HYDROCHLORI
DE
8mg
every
hours
intraven
ously
Slow IV
Competiti
ve
inhibits
action of
histamine
on theH2at
receptor
sites of
parietal
cells,decr
easinggastric
acid
secretion
* Treat
ment of
GERD.
Sympto
matic
relief commo
nly
occurs
within
24
hoursafter
starting
therapy
with
ranitidi
ne
Contraind
icated in
patients
hypersens
itive to
drug andthose
with
acute
porphyria
Vertigo,malais
e,headache,bl
urred
vision,jaundic
e ,burning and
itching oninjection
site,anaphylax
is,angioedema
Assess patient for
abdominal
painnote presence
of blood in
emesis,stool or
gastric aspirate>drug may be
added to total
parenteral nutrition
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 17/56
Generic Name Dosage/f
requency
and
Route of
admin
Action Indicatio
n
Contra-
indication
Adverse
Reaction
Nursing
Management/Co
nsideration
CYTARABINE 35 mg IV It kills
cancer
cells by
interferin
g withDNA
synthesis
Acute
non
lymphocy
tic
leukemia,acute
lymphocy
tic
leukemia
Contraindi
cated in
patients
hypersens
itive tothe drug
Neurotoxicity,
malaise,dizzine
ss
Headache,cere
bellarsyndrome,ede
ma,conjuctiviti
s,nausea,vomit
ing,diarrhea,ur
ine
retention,renaldysfunction,ra
sh pruritus
alopecia,
freckling
>for intrathecal
administration,us
e preservative-
free normal
saline solutionadd 5ml to
100mg vial or
10ml to 500 mg
vial.use
immediately
afterreconstitution.Di
scard unused
drug.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 18/56
Generic Name Dosage/f
requency
and
Route of
admin
Action Indication Contra-
indication
Adverse
Reaction
Nursing
Management/Consid
eration
PARACETAMOL 110mgevery
4hours
intraveno
uly prn
for temp
of 38
Unknownthought to
produce anlgesia
by bloking pain
impulses by
inhibiting
synthesis of prostaglandin in
the CNS or other
substances that
sensitize pain
receptors
>drug mayreieve fever
through central
action in the
hypothalamic
heat-regulating
center
Pre BTmeds:
mild pain
or fever
Contraindicated in
patients
hypersensi
tive to the
drug
Hematologic,hemoly
ticanemia,
neutropen
ia,leukope
nia
jaundicerashes,urti
caria
>many OTC andprescription products
contain aceta
minophen;be aware
of this when
calculating total daily
dose>use liquid form for
children and patients
who have difficulty of
swallowing.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 19/56
Generic Name Dosage
/freque
ncy and
Route
of
admin
Action Indication Contra-
indication
Adverse
Reaction
Nursing
Managemen
t/Considerat
ion
METOCLOPRA
MIDE
HYDROCHLORI
DE
1.8 mg
intraven
ously
Blocks
dopamin
e
receptor
s at
chemore
ceptortriggerzo
ne
To prevent
or reduce
nausea
and
vomiting
from
emetogenic cancer
chemother
apy
Contraindic
ated in
patients
hypersensi
tive to the
drug and in
those withpheochrom
ocytoma or
seizure
disorders
Contrain
dicated
in
patients
hypersen
sitive to
the drug
>monitor
bowel souds
>safety and
effectiveness
of drug
haven’t been
establishedfor therapy
lasting
longer than
12 weeks
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 20/56
Generic
Name
Dosage/fr
equency
and
Route of
admin
Action Indication Contra-
indicatio
n
Adverse
Reaction
Nursing
Management/
Consideration
DIPHENHYDR
AMINE
HYDROCHLO
RIDE
110mg IV Comple
tes
with
histami
ne for
H,-
recepto
r sites
Pre
BT med:rh
initis,allerg
y
symptoms,
motion
sickness,pa
rkinsons
disease
Contrain
dicated
in
patients
hyperse
nsitive
to the
drug
CV and
CNS
effects.Bl
ood
disorders.
Allergic
reactions
>stop drug 4
days before
diagnostic skin
testing
>Alternative
injection sites
to prevent
irritation.
>give IMinjection deep
into large
muscle
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 21/56
Generic
Name
Dosage/
frequenc
y and
Route of
admi
Action Indica
tion
Contra-
indication
Adverse
Reaction
Nursing
Management/C
onsideration
FUROSE
MIDE
10mg IV acts by
inhibit
ing
NKCC2
Post
BT m
eds:
Acute
pulmo
nary
edem
a
>Contraindicat
ed in patients
hypersensitive
to the drug
and in those
with anuria
Allergic
reaction,hy
peruricemia
;bone
marrow
depression
>to prevent
nocturia,give P.O
and I.M
preparations in
the
morning.Give
second dose in
early afternoon
Generic Dosage/ Action Indication Contra-indication Adverse Nursing
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 22/56
Generic
Name
Dosage/
frequency and
Route of admi
Action Indication Contra indication Adverse
Reaction
Nursing
Management/Considerati
on
TRANEXA
MIC ACID
110 MG IV Tranexamic acid
is a synthetic
derivative of the
amino acid
lysine. It exerts
its
antifibrinolytic
effect through
the reversible
blockade of
lysine-binding
sites on
plasminogen
molecules.
Tranexam
ic acid is
used for
the
prompt
and
effective
control of
hemorrha
ge in
various
surgical
and
clinical
areas:
Ex.patient
is on
active(mo
uth
sore)blee
ding
*
1. Allergic
reaction to
the drug or
hypersensitivi
ty
2. Presence of
blood clots
(eg, in the leg,
lung, eye,
brain), have a
history of blood clots,
or are at risk
for blood
clots
3. Current
administratio
n of factor IX
complex
concentrates
or anti-
inhibitor
coagulant
concentrates
Gastrointestinal
disturbances
(nausea,
vomiting,
diarrhea) may
occur but
disappear when
the dosage is
reduced.
Giddiness and
hypotension
have been
reported
occasionally.
Hypotension has
been observed
when
intravenous
injection is too
rapid.
1. Unusual change in
bleeding pattern
should be
immediately
reported to the
physician.
2. Tranexamic Acid
should be used with
extreme caution in
CHILDREN younger
than 18 years old;
safety and
effectiveness in
these children have
not been confirmed.
3. Inform the client
that he/she should
inform the physician
immediately if the
following severe side
effects occur:
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 23/56
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 24/56
Assessment Diagnosis Rationale Planning Nursing
intervention
Rationale Evaluation
SUBJECTIVE:
“ napansin
kong
nagdurugo
yung labi atgilagid nya” as
verbalized by
the mother.
OBJECTIVE:
Bleeding in
gums and lips
Headache and
dizziness
Blurring of
vision
T: 35.3
P: 103R: 24
BP: 90/40
RBC: 21.2
Hct: 0.28
Platelet: 28
Risk for
bleeding
related to
decreased
plateletcount
Decreased in
the platelet
resulting to
dehydration
anddecreasing
the clotting
factor.
After 8 hours of
Nursing
Intervention,
Jomach will be
protect frominfection and
bleeding hazard
that may
contribute to
patient’s health
condition and
may
demonsstrate
improvement in
vital signs,
laboratory
result, and
lessen the
difficulty of
body function.
INDEPENDENT:
Assess vital signs
every 4 hours and
body systems
every shift forbleeding:
1.Skin and mucous
membranes for
petechiae,
ecchymoses, and
hematoma
formation
2.Encourage use of
soft-bristle
toothbrushor sponge to clean
teeth and gums to
prevent bleeding
and risk of
infection
1.Suppression
of bone
marrow and
platelet
production
places patient
at risk of
spontaneous/
uncontrolled
bleeding.
2.Fragile
tissues and
alteredClotting
mechanisms
increase the
risk of
hemmorhage
following even
minor trauma.
Goal Met:
After 8 hours
of Nursing
InterventionJomach was
protected
from infection
and bleeding
hazard that
may
contribute to
patient’s
health
condition and
the mother
demonstrate
improvement
in vital signs,
laboratoryresult, and
lessen the
difficuty of
body function.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 25/56
Assessment Diagnosis Rationale Planning Nursing intervention Rationale Evaluation
3. Limit oral care to
mouthwash if
indicated (a mixture of
1 tsp baking soda or
salt in 4-8 oz water orhydrogen peroxide in
water) avoid a
mouthwash with
alcohol.
4. Provide soft diet.
COLLABORATIVE:
1. Administer IV fuids
as indicated.
3. When beeding is
present, even gentle
brushing more cause
more tissue damage.
Alcohol has a dyingeffect and may
painful to irritated
tissues.
4. May help reduce
gum irritation.
1.Maintains
fluid/electrolyte
balance in the
abscence of oral
intake; prevents orminimizes tumor
lysis syndrome,
reduces risk of renal
complications.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 26/56
Assessment Diagnosis Rationale Planning Nursing intervention Rationale Evaluation
2. Administer
medications as
indicated,e.g.:
Antiemetics: 5-HT,
receptor antagonist
drugs such as
ordanseton (Zofran) or
granisetron (Kytril);
Allopurinol
(Zylopoprim)
Potassium acetate or
citrate, sodium
bicarbonate;
2. Relieves
nausea/vomiting
associated with
administration of
chemotherapy agents.
Improves renal
excretion of toxic by
products from
breakdown of leukemia cells.
Reduces the chances
of nephropthy as a
result of uric acid
production.
May be used to
alkalinize the urine,
preventing or
minimizing tumor lysis
sydney/kidney stones.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 27/56
Assessmen
t
Diagnosis Rationale Planning Nursing intervention Rationale Evaluation
Stool softeners.
Administer RBCs,
plateles, clotting
factors.
Helpful in reducing
straining at stool with
trauma to rectal
tissues
Restores/normalizes
RBC count and
oxygen-carrying
capacity to correct
anemia. Used to
prevent/treat
hemmorhage.
i i i l l i i i l l i
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 28/56
Assessment Diagnosis Rationale Planning Nursing
intervention
Rationale Evaluation
SUBJECTIVE:
“Napansin ko
na
madalas
mgkaroon ng ng
pasa at palaging
pagod at
nanghihina si
Jomach”
as verbalized by
the
mother
OBJECTIVE:
Irritability
Pallor of skin
and mucous
membranes
V/S taken as
follows
T: 35.3
P: 103
R: 24
BP: 90/40
Risk for
infection
related
to
inadequa
te
primary
defenses
Decreased
in the
ability to
guard self
from
internal or
external
threats
such as
illness or
injury.
After 8 hours
of
nursing
interventions
the
patient will
identify
actions to
prevent or
reduce
the risk for
infection.
INDEPENDENT:
1. Require good
handwashing
protocol for all
personnel and
visitors.
2. Place the
patient in private
room. Limit
visitors as
indicated.
Prohibit use of
live plants or cut
flowers.
3. Restrict fresh
fruits and
vegetables or
make sure they
are washed or
peeled.
1. Prevents
stasis of
respiratory
secretions,
reducing risk
of atelectasis
or
pneumonia.
2. Protect
patient from
potential
sources of
pathogens or
infection.
3. Prevents
crosscontami
nation
or reduce risk
for infection.
After 8 hours
of
nursing
interventions
the
patient was
able to
identify
actions to
prevent or
reduce
the risk for
infection.
A Di i R i l Pl i N i i i R i l E l i
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 29/56
Assessmen
t
Diagnosi
s
Rationale Plannin
g
Nursing intervention Rationale Evaluation
COLLABORATIVE:
1. Prepare for or
assist patient with
leukemia
treatments such as
chemotherapy,
radiation, and bone
marrow
transplantation.
2. Administer
antibiotics as
indicated.
1. Leukemia is usually
treated with a
combination of these
agents, each requiring
specific safety
precautions for patient
and care providers.
2. May be given
prophylactically or
to treat specific
infection.
A t Di i R ti l Pl i N i R ti l E l ti
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 30/56
Assessment Diagnosis Rationale Planning Nursing
intervention
Rationale Evaluation
Subjective
Cue(s):
“Nahihirapan
po syang
huminga ” as
verbalized by
the mother
Objective
Cue(s):
-V/S:
RR: 36
PR: 84
Nausea
Pallor/palene
ss
Weakness
Easy
fatigability
Headache and
dizziness
Ineffectiv
e Tissue
Perfusion
r/t
Inadequa
tte red
bood cell
producti
on as
manifest
ed by
bradypne
a,
tachycard
ia,
Nausea
Abdomin
al pain
Pallor
Weaknes
s
Easy
fatigabilit
y
Decreased
in oxygen
resulting
in the
failure to
nourish
the
tissues at
the
capillary
level.
After 8 hours of
Nursing
Intervention,
Jomach will
demonstrate
increased tissue
perfusion as
individually
appropriate.
OBJECTIVES:
A.) To identify
causative/contri
buting factors.
B.) To assist
client to
correct/minimize
impairment and
to promote
healing.
C.) To promote
wellness.
A. To identify
causative/contrib
uting factors.
Independent:
1. Note reports of
increasing
fatigue,
weakness.
Observe for
tachycardia,
pallor of
skin/mucous
membranes,
dyspnea, and
chestpain. Plan of
patient activities
to avoid fatigue.
2. Note poor
hygiene/health
practices(e.g. lack
of cleanliness,
poor dental care.)
1.May reflect
effects of
anemia and
cardiac
responses. To
let the
patient rest.
2. May
impacting
tissue health.
Goal Met:
After 8 hours
of Nursing
Intervention,
Jomach
demonstrate
increased
tissue
perfusion as
individually
appropriate.
A. Causative
contributors
and been
identified.
A Di R ti l Pl i N i i t ti R ti l E l ti
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 31/56
Assess
ment
Diagn
osis
Rationale Planning Nursing intervention Rationale Evaluation
B. To assist client to
correct/minimize
impairment and to
promote healing.
1. Monitor V/S and
monitor I and O.
2. Elevate HOB(10
degrees) andmaintain
head/neck in midline or
neutral position.
3. Encourage quiet, restful
atmosphere.
4. Caution patient to
avoid activities that
increase cardiac workload
(e.g., straining at stool).
5. Provide small/ easily
digested food and fluids,
when tolerated and
encourage rest after
meals.
1. To have a baseline
data.
2. To promote
circulation/venous
drainage.
3. Conserves energy/
lowers tissue Oxygen
Demand.
4. To lessen the work of
the heart.
5. To maximize blood
flow to stomach,
enhancing digestion.
B.
Correct/Mini
mize
impairment
and to
promote
client’s
healing has
been
assisted.
Assess Diagnosis Rationale Planning Nursing intervention Rationale Evaluation
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 32/56
Assess
ment
Diagnosis Rationale Planning Nursing intervention Rationale Evaluation
Collaborative:
1. Asssess blood supply
and sensation(nerve
damage) of affected
area.
2. Evaluates
pulses/calculate ankle-
brachial index.
1. To evaluate
actual/potential for
impairment of circulation
to lower extremities.
2. Result less than 0.9
indicates need for close
monitoring/ more
agressive intervention.
C. Wellness
had been
promoted.
Assessment Diagnosis Rationale Planning Nursing Rationale Evaluation
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 33/56
Assessment Diagnosis Rationale Planning Nursing
intervention
Rationale Evaluation
Subjective:
“Puro pasa
yung
katawan niya
at hinang-
hina siya.” As
verbalized by
the mother.
Pain
Scale:3/5
Objective:
decreased
RR(25cpm),
decreased
CR(90bpm),
sunken
eyeballs,
pale-looking,
petechiae,
fever
(temp:38.0)
Acute pain
related to
physical
agents—
enlarged
organs and
lymph
nodes, bone
marrow
packed with
leukemic
cells,
chemical
agents—
antileukemi
c
treatments,
psychologic
al
manifestatio
ns—anxiety,
fear
Acute lymphocytic
leukemia (ALL)
occurs when the
the body produces
a large number of
immature white
blood cells, called
lymphocytes. The
cancer cells quickly
grow and replace
normal cells in the
bone marrow. Bone
marrow is the soft
tissue in the center
of bones that helps
form blood cells.
ALL prevents
healthy blood cells
from being made.
Life-threatening
symptoms can
occur.
After 24 hours
of nursing
intervention
client will be
relieved of
pain in relation
to having signs
and symptoms
of acute
lymphocytic
leukemia, will
appear relaxed
and able to
sleep and rest
appropriately,
and will
demonstrate
behaviors of
managing pain.
1.Investigat
e reports of
pain. Note
changes in
degree (use
scale of 0 to
10) and site.
2. Monitor
vital signs
and note
nonverbal
cues, such
as muscle
tension and
restlessness
.
1.Helpful
in
assessing
need for
interventi
on and
may
indicate
developin
g
complicati
ons.
2.May be
useful in
evaluating
verbal
comments
and
effectiven
ess of
interventi
ons.
After 24
hours of
nursing
intervention
client was
relieved of
pain in
relation to
having signs
and
symptoms of
acute
lymphocytic
leukemia,
appeared
relaxed and
able to sleep
and rest
appropriately
, and
demonstrate
d behaviours
of managing
pain.
Assess Diagnosis Rationale Planning Nursing intervention Rationale Evaluation
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 34/56
Assess
ment
Diagnosis Rationale Planning Nursing intervention Rationale Evaluation
3. Provide quiet
environment and reduce
stressful stimuli: noise,
lighting, and constant
interruptions.
4. Place in position of
comfort, and support
joints and extremities
with pillows and other
padding.
5. Reposition periodically
and provide or assist
with gentle range-of-
motion (ROM) exercises.
3.Promotes rest and
enhances coping
abilities.
4.May decrease
associated bone and
joint discomfort.
5.Improves tissue
circulation and joint
mobility.
Assessment Diagnosis Rationale Planning Nursing Rationale Evaluation
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 35/56
Assessment Diagnosis Rationale Planning Nursing
intervention
Rationale Evaluation
Subjective:
“Walang
ganang
kumain ang
anak ko.” As
verbalized
by mother.
Objective:
Decreased
CR(85bpm),
Decreased
RR(20cpm),
Weight: 6lbs
Inflamed
oral mucous
membrane,
Pale-
looking,Sunken
eyeballs
Altered
Nutrition
: Less
than
Body
Requirem
ents
related
to
Loss of
Appetite
and
Weaknes
s
Imbalance
nutrition: less than
body
requirements
refers to an intake
of nutrients
insufficient to
meet daily
requirements
because of
inadequate food
intake or improper
digestion and
absorption of
food. An
inadequate food
intake may be
caused by the
inability to acquireor prepare food,
inadequate
knowledge about
essential nutrients
and a balanced
diet.
After 24
hours of
therapeutic
nursing
interventio
n, client
will
demonstrat
e good
appetite,
will
improve
nutrition
status, and
will
manifest
appropriat
e daily
activities.
1.Weigh
regularly and
evaluate
weightloss over
time.
2. Offer client
small but
frequent
mealand snacks
including low-
fat,high-caloric
food e.g.,
potatoes,
bread.
3. Give
supplemental
nutritione.g.,multivitami
ns
1.To determine
degree of
malnutrition.
2. Bigmeal will
suppress the
appetite
andsmall-
frequent meal
are often better
tolerated.
3. To improve
the nutritional
status.
Goal met.
After 24
hours of
therapeutic
nursing
interventio
n, client
demonstrat
ed good
appetite,
improved
nutrition
status, and
manifested
appropriat
e daily
activities.
Assess Diagnosis Rationale Planning Nursing intervention Rationale Evaluation
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 36/56
Assess
ment
Diagnosis Rationale Planning Nursing intervention Rationale Evaluation
4.Increase fluid intake
5. Arrange dietician to
discuss with client or
family on proper diet
intake and helpful dietary
medifications.
4.To promote good
hydration
5.To improve the
nutritional status.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 37/56
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 38/56
I. DISCHARGE GOAL
a. Complications prevented/minimized
b. Pain relieved/controlled
c. Dealing with desease realistically
d. Disease process/prognosis and therapeutic
regimen understood
e. Plan in place to needs after discharge
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 39/56
II. Medication
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 40/56
III. Diet
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 41/56
IV.FOLLOW UP VISIT/CHECK-UP
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 42/56
V. IMPORTANT HEALTH TEACHING
INCLUDES
A. Pay attention on medication regimen, dietaryand fluid restriction.
B. Eat well, good nutrition can help to feel
better during treatment and diseasetreatment side effects, decrease risk forinfection, and help to maintain a healthyweight and heal faster (Eat small-frequent
meal and snacks rather than 1 big mealwhich will only suppress the appetite.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 43/56
C. Drink fluids about 2-3liters each day or
prescribe the Doctor.
D. Avoid constipation. These can irritate the
rectum which can cause infection.
E. Rest (going to bed early and getting up late
may also help)
F. Exercise keeps you healthy.
Decrease activities if blood count is low
based on the result of blood test.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 44/56
VI. SEEK IMMEDIATELY IF:
A. Have headache, blurred vision, stiff neck, or
have trouble thinking.
B. Coughing out of blood (this may be a serious
bleeding inside the body)
C. Have chest pain
D. Have trouble breathing
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 45/56
VII. NURSING PRIORITIES
A. Prevent infection during acute phases of
disease/treatment
B. Maintain circulating blood volume
C. Alleviate pain
D. Promote optimal physical functioning
E. Provide psychological supportF. Provide information about disease
process/prognosis and treatment
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 46/56
VII. SIGNS OF AN INFECTIONS
A. sores, swelling, redness, or white patches in themouth or throat.
B. Redness, pain, hemorrhoids in the rectum
C. Diarrhea
D. Heat or pain in the eyes, ears, skin, joints, orabdomen
E. Pain or burning when urinating, or bad smelling
urineF. Coughing, trouble breathing or changes in thecolor of sputum
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 47/56
VIII. INFECTION PROTECTION
• Place in room screen/limit visitors as
indicated.
• Prohibit use of live plants/cut flowers. Restrict
fresh fruits and vegetables or make it sure
they are wash or peeled.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 48/56
IX. BLEEDING PRECAUTIONS
• Inspect skin/mucus membranes for petechiae,
ecchymotic areas, note bleeding gums, frank
or occult blood in the stool and urine, oozing
for invasive line sites
X PAIN MANAGEMENT
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 49/56
X. PAIN MANAGEMENT
• Place in position of comfort and support
joints, extremities, with pillows/padding.
• Evaluate reports of fatigue, inability to
participate in activities.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 50/56
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 51/56
Summary
Acute lymphocytic leukemia (ALL), also
called acute lymphoblastic leukemia, is a cancer
that starts from white blood cells calledlymphocytes in the bone marrow (the soft inner
part of the bones, where new blood cells are
made).
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 52/56
This study helps the student to:
• Know more about the lymphocytic leukemia.
• Determine the difference between lymphoblastic
and lymphocytic leukemia.• Be familiarized with the different procedures
done to the patient.
• Know more about the appropriate assessments
regarding the lymphocytic leukemia.
• Know the different method and treatments onlymphocytic leukemia.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 53/56
Recommendations
• For most people, the cause of ALL is unknown.
For this reason, there is no known way to
prevent it. However, there are a few knownrisk factors for this type of leukemia.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 54/56
Risk Factors
• Avoid Exposure to high levels of radiation to
treat other types of cancer
• Avoid Exposure to certain chemicals such asbenzene, a solvent used in oil refineries and
other industries and present in cigarette
smoke, certain cleaning products, detergents,and paint strippers
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 55/56
• Reduce Infection with human T-cell
lymphoma/leukemia virus-1 (HTLV-1) in rarer
cases outside the U.S. or Epstein-Barr virus(EBV), a related leukemia more commonly
seen in Africa.
7/28/2019 Case Pres PPT
http://slidepdf.com/reader/full/case-pres-ppt 56/56